| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Io Biotech, Inc. (IOBT) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. IOBT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 35.1K | $1.7K | - | |
| ? | 35.1K | $1.7K | - | |
| ? | 35.1K | $1.7K | - | |
| ? | 35.1K | $1.7K | - | |
| ? | 35.1K | $1.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Vivo Capital Ix, LLC57 | 10% Owner | Buy | 3,157,894 | $1.90 | $5,999,998.60 | New | -45.8% | -20.0% | |
| Mar 17, 2023 | Sullivan Amy | Chief Financial Officer | Buy | 25,000 | $2.32 | $58,017.50 | New | +3.5% | -16.7% | |
| Nov 9, 2021 | Andersson Claus A. | Director | Buy | 75,000 | $14.00 | $1,050,000.00 | +4.4% | -36.9% | -81.2% | |
| Nov 9, 2021 | Novo Holdings A/s58 | 10% Owner | Buy | 325,000 | $14.00 | $4,550,000.00 | +11.0% | -36.9% | -81.2% | |
| Nov 9, 2021 | Malier Vanessa | Director | Buy | 325,000 | $14.00 | $4,550,000.00 | +30.5% | -36.9% | -81.2% | |
| Nov 9, 2021 | Vivo Capital Ix, LLC57 | 10% Owner | Buy | 650,000 | $14.00 | $9,100,000.00 | +27.5% | -36.9% | -81.2% | |
| Nov 9, 2021 | Lundbeckfond Invest A/s | 10% Owner | Buy | 2,142,857 | $14.00 | $29,999,998.00 | +54.9% | -36.9% | -81.2% | |
| Nov 9, 2021 | Hbm Healthcare Investments (cayman) Ltd. | 10% Owner | Buy | 325,000 | $14.00 | $4,550,000.00 | +13.7% | -36.9% | -81.2% | |
| Nov 9, 2021 | Nielsen Jack76 | Director | Buy | 650,000 | $14.00 | $9,100,000.00 | +27.5% | -36.9% | -81.2% |